Islet immunity and beta cell reserve of indigenous Black South Africans with ketoacidosis at initial diagnosis of diabetes

Ethnicity and Disease

Volumn 23, Issue 2, 2013, Pages 196-201

  Ekpebegh, Chukwuma ^a   Longo Mbenza, Benjamin ^a   Blanco Blanco, Ernesto ^a  

^a WALTER SISULU UNIVERSITY   (South Africa)

Author keywords

Beta cell reserve; Black South African; Diabetes; Islet immunity; Ketoacidosis

Indexed keywords

C PEPTIDE; GLUCAGON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AUTOANTIBODIES; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETIC KETOACIDOSIS; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SOUTH AFRICA; YOUNG ADULT;

EID: 84875784939     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kitabchi AE, Murphy MB, Umpierrez GE, Kreisberg RA. Hyperglycemic crisis in adult patients with diabetes. Diabetes Care. 2006; 29(12):2739-2748.
2. Umpierrez GE, Murphy MB, Kitabchi AE. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Diabetes Spectrum. 2002;15(1):28-36.
3. Chiasson J, Aris-Jilwan N, Be'longer R, et al. Diagnosis and treatment of diabetic diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168(7):859-866.
4. Balasubramanyam A, Zein JW, Hyman DJ, Pavlik V. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Arch of IntMed. 1999;159(19):2317-2322.
5. Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994;43(6):741-745.
6. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS. Diabetic ketoacidosis in obese African Americans. Diabetes. 1995;44(7):790-795.
7. Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999;22(9):1517-1523.
8. Yu E, Guo H, Wu T. Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. Diabet Med. 2001;18(11):895-899.
9. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care. 2001;24(6):1014-1018.
10. Sobngwi E, Vexiau P, Levy V, et al. Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med. 2002;19(10): 832-835.
11. Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. ketosis-prone type 2 diabetes mellitus in patients of Sub-Saharan African origin: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645-653.
12. Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis and clinical outcomes. J Clin Endocrinol Metab. 2003;88(1):5090-5098.
13. Balasubramanyam A, Nalini R, Hampe CS, Maldonado M. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008;29(3): 292-302.
14. Lester FT. Ketoacidosis in Ethiopian diabetes. Diabetologia. 1980;18(5):375-377.
15. Pepper DJ, Levitt NS, Cleary S. Hyperglycemic emergency admissions to a secondary-level hospital-an unnecessary financial burden. JEMDSA. 2007;12(2):963-967.
16. Rheeder P, Stolk RP, Grobbee DE. Ethnic differences in c-peptide levels and anti GAD antibodies in South African patients with diabetic ketoacidosis. Q J Med. 2001;94:39-42.
17. Mbugua DK, Otieno CF, Kayima JK, Amayo AA, Mcligeyo SO. Diabetic ketoacidosis. Clinical presentation and precipitating factors at Kenyatta National Hospital. East Afr Med J. 2005;8(Suppl 12):S191-S196.
18. Ekpebegh CO, Longo-Mbenza B, Akinrinmade A, Blanco-Blanco E, Badri M, Levitt NS. Hyperglycemic crisis in the Eastern Cape Province of South Africa: High mortality and the association of hyperosmolar ketoacidosis with a new diagnosis of diabetes. SAMJ. 2010; 100(12):822-826.
19. American Diabetes Association. Hyperglycemic crisis in diabetes. Diabetes Care. 2004;27 (S1):S94-S102.
20. Zimmet P, Magliano D, Matsuzawa Y, Albert G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6): 295-300.
21. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pr. 2010;87(1):4-14.
22. Aguilera E, Oriola J, Casamitjana R, Gomis R, Ercilla G, Conget I. Adult onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care. 2004;27(5): 1108-1114.
23. Weir GC, Laybutt DR, KanetoH, Bonner-Weir S, Sharma A. B cell adaptation and decompensation during the progression of diabetes. Diabetes. 2001;50(Supp 1):S154-S159.
24. Kraegen EW, Cooney GJ, Ye JM, Thompson AI, Furler SM. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type 2 diabetes and obesity. Exp Clin Endocrinol Diabetes. 2001;109:5189-5201.
25. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5 year experience. Diabetes Care. 2001;24(6):1014-1018.